Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Adamzik

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Plos One|June 2, 2016
NFKB1 Promoter DNA from nt+402 to nt+99 Is Hypomethylated in Different Human Immune CellsMatthias Unterberg, Maxmiliane Julia Kreuzer, Simon Thomas Schäfer, et al.
Trials|May 31, 2025
Effects of passive blood-flow-restriction and electromyostimulation on ICU-acquired weakness (ICUAW): a study protocol for a randomized-controlled, parallel-group clinical trialAlexander Franz, Katharina Friederike Wolf, Julika Behrens, et al.
Cells|April 11, 2020
Major Adverse Kidney Events Are Associated with the Aquaporin 5 -1364A/C Promoter Polymorphism in Sepsis: A Prospective Validation StudyLars Bergmann, Hartmuth Nowak, Winfried Siffert, et al.
GMS Infectious Diseases|January 24, 2019
Decreased protein binding of moxifloxacin in patients with sepsis?Christoph Dorn, Hartmuth Nowak, Caroline Weidemann, et al.
BMC Anesthesiology|July 31, 2016
Phrenic nerve block caused by interscalene brachial plexus block: breathing effects of different sites of injectionLars Bergmann, Stefan Martini, Miriam Kesselmeier, et al.
Intensive Care Medicine|May 1, 2007
Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndromeMichael Adamzik, Ulrich H Frey, Kathrin Rieman, et al.
Breast Cancer Research and Treatment|March 24, 2009
Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomasFriedrich Otterbach, Rainer Callies, Michael Adamzik, et al.
Critical Care Medicine|May 23, 2008
Factor V Leiden mutation is associated with improved 30-day survival in patients with acute respiratory distress syndromeMichael Adamzik, Ulrich H Frey, Kathrin Riemann, et al.
Critical Care (London, England)|December 14, 2017
Comparison of mortality prediction models in acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation and development of a novel prediction score: the PREdiction of Survival on ECMO Therapy-Score (PRESET-Score)Michael Hilder, Frank Herbstreit, Michael Adamzik, et al.
Intensive Care Medicine|August 17, 2013
An increased alveolar CD4 + CD25 + Foxp3 + T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortalityMichael Adamzik, Jasmin Broll, Jörg Steinmann, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Plos One|June 2, 2016
NFKB1 Promoter DNA from nt+402 to nt+99 Is Hypomethylated in Different Human Immune CellsMatthias Unterberg, Maxmiliane Julia Kreuzer, Simon Thomas Schäfer, et al.
Trials|May 31, 2025
Effects of passive blood-flow-restriction and electromyostimulation on ICU-acquired weakness (ICUAW): a study protocol for a randomized-controlled, parallel-group clinical trialAlexander Franz, Katharina Friederike Wolf, Julika Behrens, et al.
Cells|April 11, 2020
Major Adverse Kidney Events Are Associated with the Aquaporin 5 -1364A/C Promoter Polymorphism in Sepsis: A Prospective Validation StudyLars Bergmann, Hartmuth Nowak, Winfried Siffert, et al.
GMS Infectious Diseases|January 24, 2019
Decreased protein binding of moxifloxacin in patients with sepsis?Christoph Dorn, Hartmuth Nowak, Caroline Weidemann, et al.
BMC Anesthesiology|July 31, 2016
Phrenic nerve block caused by interscalene brachial plexus block: breathing effects of different sites of injectionLars Bergmann, Stefan Martini, Miriam Kesselmeier, et al.
Intensive Care Medicine|May 1, 2007
Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndromeMichael Adamzik, Ulrich H Frey, Kathrin Rieman, et al.
Breast Cancer Research and Treatment|March 24, 2009
Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomasFriedrich Otterbach, Rainer Callies, Michael Adamzik, et al.
Critical Care Medicine|May 23, 2008
Factor V Leiden mutation is associated with improved 30-day survival in patients with acute respiratory distress syndromeMichael Adamzik, Ulrich H Frey, Kathrin Riemann, et al.
Critical Care (London, England)|December 14, 2017
Comparison of mortality prediction models in acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation and development of a novel prediction score: the PREdiction of Survival on ECMO Therapy-Score (PRESET-Score)Michael Hilder, Frank Herbstreit, Michael Adamzik, et al.
Intensive Care Medicine|August 17, 2013
An increased alveolar CD4 + CD25 + Foxp3 + T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortalityMichael Adamzik, Jasmin Broll, Jörg Steinmann, et al.
Pageof 13